Algert Global’s Invacare Corporation IVC Stock Holding History

Algert Global’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,850	Closed	-$24K	–	1434
2022 Q1	$24K	Buy	+16,850	New	+$36K	﹤0.01%	1156

Other funds holding IVC

RCM

Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Algert Global's IVC Position: Q2 2022 in Review

Algert Global sold out of Invacare Corporation (IVC) in Q2 2022, closing a stake of 16,850 shares — an estimated $24K sold.

Algert Global first reported a position in IVC in Q1 2022 and held it in 1 quarter. The position peaked at $24K in Q1 2022. 83 funds tracked by Wall St. Rank hold IVC as of Q2 2022.

Algert Global reported no remaining Invacare Corporation position as of Q2 2022 after selling out during the quarter.
Algert Global sold 16,850 Invacare Corporation shares in Q2 2022, an estimated $24K.
Algert Global first reported a position in Invacare Corporation in Q1 2022 and held it in 1 quarter.
Algert Global's Invacare Corporation position peaked at $24K in Q1 2022.
83 funds tracked by Wall St. Rank held Invacare Corporation as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.